Trillium Asset Management LLC Sells 51 Shares of Waters Co. (NYSE:WAT)

Trillium Asset Management LLC cut its position in Waters Co. (NYSE:WAT) by 2.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,116 shares of the medical instruments supplier’s stock after selling 51 shares during the quarter. Trillium Asset Management LLC’s holdings in Waters were worth $785,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the company. OneDigital Investment Advisors LLC boosted its position in Waters by 3.8% during the 3rd quarter. OneDigital Investment Advisors LLC now owns 851 shares of the medical instruments supplier’s stock worth $306,000 after buying an additional 31 shares during the period. Swiss National Bank raised its stake in shares of Waters by 0.4% during the third quarter. Swiss National Bank now owns 176,100 shares of the medical instruments supplier’s stock valued at $63,377,000 after acquiring an additional 700 shares during the last quarter. Pathstone Holdings LLC lifted its holdings in shares of Waters by 1.7% during the third quarter. Pathstone Holdings LLC now owns 3,916 shares of the medical instruments supplier’s stock worth $1,409,000 after purchasing an additional 65 shares during the period. Banque Cantonale Vaudoise grew its stake in shares of Waters by 0.5% in the third quarter. Banque Cantonale Vaudoise now owns 10,868 shares of the medical instruments supplier’s stock worth $3,912,000 after purchasing an additional 57 shares during the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG bought a new stake in shares of Waters in the third quarter worth $1,631,000. 94.01% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

WAT has been the topic of several recent research reports. StockNews.com downgraded Waters from a “buy” rating to a “hold” rating in a report on Tuesday, February 25th. JPMorgan Chase & Co. raised their price objective on Waters from $380.00 to $390.00 and gave the stock a “neutral” rating in a research report on Thursday, March 6th. Sanford C. Bernstein upgraded Waters from a “market perform” rating to an “outperform” rating and set a $430.00 target price on the stock in a report on Friday, January 10th. Scotiabank upgraded shares of Waters from a “sector perform” rating to a “sector outperform” rating and raised their price target for the stock from $430.00 to $450.00 in a report on Thursday, February 13th. Finally, Wells Fargo & Company upped their price objective on shares of Waters from $415.00 to $420.00 and gave the company an “overweight” rating in a research note on Thursday, February 13th. Eleven research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $391.07.

Waters Stock Performance

Shares of Waters stock opened at $371.61 on Thursday. The business has a 50-day simple moving average of $391.31 and a 200 day simple moving average of $370.98. Waters Co. has a one year low of $279.24 and a one year high of $423.56. The company has a debt-to-equity ratio of 1.14, a current ratio of 0.94 and a quick ratio of 0.65. The firm has a market capitalization of $22.08 billion, a price-to-earnings ratio of 34.70, a PEG ratio of 3.79 and a beta of 1.00.

Waters (NYSE:WAT) last issued its earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share for the quarter, topping analysts’ consensus estimates of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. On average, research analysts anticipate that Waters Co. will post 12.86 earnings per share for the current fiscal year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.